LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 45

Search options

  1. Article ; Online: The Pancreatic ß-cell Response to Secretory Demands and Adaption to Stress.

    Kalwat, Michael A / Scheuner, Donalyn / Rodrigues-Dos-Santos, Karina / Eizirik, Decio L / Cobb, Melanie H

    Endocrinology

    2021  Volume 162, Issue 11

    Abstract: Pancreatic β cells dedicate much of their protein translation capacity to producing insulin to maintain glucose homeostasis. In response to increased secretory demand, β cells can compensate by increasing insulin production capability even in the face of ...

    Abstract Pancreatic β cells dedicate much of their protein translation capacity to producing insulin to maintain glucose homeostasis. In response to increased secretory demand, β cells can compensate by increasing insulin production capability even in the face of protracted peripheral insulin resistance. The ability to amplify insulin secretion in response to hyperglycemia is a critical facet of β-cell function, and the exact mechanisms by which this occurs have been studied for decades. To adapt to the constant and fast-changing demands for insulin production, β cells use the unfolded protein response of the endoplasmic reticulum. Failure of these compensatory mechanisms contributes to both type 1 and 2 diabetes. Additionally, studies in which β cells are "rested" by reducing endogenous insulin demand have shown promise as a therapeutic strategy that could be applied more broadly. Here, we review recent findings in β cells pertaining to the metabolic amplifying pathway, the unfolded protein response, and potential advances in therapeutics based on β-cell rest.
    MeSH term(s) Adaptation, Physiological/physiology ; Animals ; Endoplasmic Reticulum/metabolism ; Endoplasmic Reticulum Stress/physiology ; Humans ; Insulin Secretion/physiology ; Insulin-Secreting Cells/physiology ; Unfolded Protein Response/physiology
    Language English
    Publishing date 2021-08-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 427856-2
    ISSN 1945-7170 ; 0013-7227
    ISSN (online) 1945-7170
    ISSN 0013-7227
    DOI 10.1210/endocr/bqab173
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Adiponectin receptor fragmentation in mouse models of type 1 and type 2 diabetes.

    Frabutt, Dylan / Stull, Natalie / Pineros, Annie R / Tersey, Sarah A / Scheuner, Donalyn / Mastracci, Teresa L / Pugia, Michael J

    Archives of autoimmune diseases

    2021  Volume 1, Issue 1, Page(s) 3–13

    Abstract: The protein hormone adiponectin regulates glucose and fatty acid metabolism by binding to two PAQR-family receptors (AdipoR1 and AdipoR2). Both receptors feature a C-terminal segment which is released by proteolysis to form a freely circulating C- ... ...

    Abstract The protein hormone adiponectin regulates glucose and fatty acid metabolism by binding to two PAQR-family receptors (AdipoR1 and AdipoR2). Both receptors feature a C-terminal segment which is released by proteolysis to form a freely circulating C-terminal fragment (CTF) found in the plasma of normal individuals but not in some undefined diabetes patients. The AdipoR1-CTF
    Language English
    Publishing date 2021-07-21
    Publishing country United States
    Document type Journal Article
    DOI 10.46439/autoimmune.1.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Deoxyhypusine synthase promotes a pro-inflammatory macrophage phenotype.

    Anderson-Baucum, Emily / Piñeros, Annie R / Kulkarni, Abhishek / Webb-Robertson, Bobbie-Jo / Maier, Bernhard / Anderson, Ryan M / Wu, Wenting / Tersey, Sarah A / Mastracci, Teresa L / Casimiro, Isabel / Scheuner, Donalyn / Metz, Thomas O / Nakayasu, Ernesto S / Evans-Molina, Carmella / Mirmira, Raghavendra G

    Cell metabolism

    2021  Volume 33, Issue 9, Page(s) 1883–1893.e7

    Abstract: The metabolic inflammation (meta-inflammation) of obesity is characterized by proinflammatory macrophage infiltration into adipose tissue. Catalysis by deoxyhypusine synthase (DHPS) modifies the translation factor eIF5A to generate a hypusine (Hyp) ... ...

    Abstract The metabolic inflammation (meta-inflammation) of obesity is characterized by proinflammatory macrophage infiltration into adipose tissue. Catalysis by deoxyhypusine synthase (DHPS) modifies the translation factor eIF5A to generate a hypusine (Hyp) residue. Hypusinated eIF5A (eIF5A
    MeSH term(s) Adipose Tissue/metabolism ; Animals ; Inflammation/metabolism ; Macrophages/metabolism ; Mice ; Oxidoreductases Acting on CH-NH Group Donors/chemistry ; Oxidoreductases Acting on CH-NH Group Donors/genetics ; Oxidoreductases Acting on CH-NH Group Donors/metabolism ; Phenotype
    Chemical Substances Oxidoreductases Acting on CH-NH Group Donors (EC 1.5.-) ; deoxyhypusine synthase (EC 1.5.1.-)
    Language English
    Publishing date 2021-09-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2021.08.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.

    Scheuner, Donalyn / Kaufman, Randal J

    Endocrine reviews

    2008  Volume 29, Issue 3, Page(s) 317–333

    Abstract: The endoplasmic reticulum (ER) is the entry site into the secretory pathway for newly synthesized proteins destined for the cell surface or released into the extracellular milieu. The study of protein folding and trafficking within the ER is an extremely ...

    Abstract The endoplasmic reticulum (ER) is the entry site into the secretory pathway for newly synthesized proteins destined for the cell surface or released into the extracellular milieu. The study of protein folding and trafficking within the ER is an extremely active area of research that has provided novel insights into many disease processes. Cells have evolved mechanisms to modulate the capacity and quality of the ER protein-folding machinery to prevent the accumulation of unfolded or misfolded proteins. These signaling pathways are collectively termed the unfolded protein response (UPR). The UPR sensors signal a transcriptional response to expand the ER folding capacity, increase degradation of malfolded proteins, and limit the rate of mRNA translation to reduce the client protein load. Recent genetic and biochemical evidence in both humans and mice supports a requirement for the UPR to preserve ER homeostasis and prevent the beta-cell failure that may be fundamental in the etiology of diabetes. Chronic or overwhelming ER stress stimuli associated with metabolic syndrome can disrupt protein folding in the ER, reduce insulin secretion, invoke oxidative stress, and activate cell death pathways. Therapeutic interventions to prevent polypeptide-misfolding, oxidative damage, and/or UPR-induced cell death have the potential to improve beta-cell function and/or survival in the treatment of diabetes.
    MeSH term(s) Animals ; Apoptosis/physiology ; Diabetes Mellitus/metabolism ; Endoplasmic Reticulum/chemistry ; Endoplasmic Reticulum/metabolism ; Humans ; Insulin/metabolism ; Insulin-Secreting Cells/metabolism ; Protein Folding ; Signal Transduction/physiology
    Chemical Substances Insulin
    Language English
    Publishing date 2008-04-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 603096-8
    ISSN 1945-7189 ; 0163-769X
    ISSN (online) 1945-7189
    ISSN 0163-769X
    DOI 10.1210/er.2007-0039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity.

    Jang, Insook / Pottekat, Anita / Poothong, Juthakorn / Yong, Jing / Lagunas-Acosta, Jacqueline / Charbono, Adriana / Chen, Zhouji / Scheuner, Donalyn L / Liu, Ming / Itkin-Ansari, Pamela / Arvan, Peter / Kaufman, Randal J

    eLife

    2019  Volume 8

    Abstract: Regulated proinsulin biosynthesis, disulfide bond formation and ER redox homeostasis are essential to prevent Type two diabetes. In ß cells, protein disulfide isomerase A1 (PDIA1/ ...

    Abstract Regulated proinsulin biosynthesis, disulfide bond formation and ER redox homeostasis are essential to prevent Type two diabetes. In ß cells, protein disulfide isomerase A1 (PDIA1/
    MeSH term(s) Animals ; Diabetes Mellitus, Type 2/genetics ; Diabetes Mellitus, Type 2/metabolism ; Diet, High-Fat/adverse effects ; Disulfides/metabolism ; Endoplasmic Reticulum/metabolism ; Glucose Intolerance/genetics ; Glucose Intolerance/metabolism ; Insulin/metabolism ; Insulin-Secreting Cells/metabolism ; Mice, Knockout ; Mice, Transgenic ; Mitochondrial Swelling ; Obesity/etiology ; Obesity/genetics ; Obesity/metabolism ; Oxidative Stress ; Procollagen-Proline Dioxygenase/genetics ; Procollagen-Proline Dioxygenase/metabolism ; Proinsulin/metabolism ; Protein Disulfide-Isomerases/genetics ; Protein Disulfide-Isomerases/metabolism
    Chemical Substances Disulfides ; Insulin ; Proinsulin (9035-68-1) ; Procollagen-Proline Dioxygenase (EC 1.14.11.2) ; P4hb protein, mouse (EC 5.3.4.1) ; Protein Disulfide-Isomerases (EC 5.3.4.1)
    Language English
    Publishing date 2019-06-11
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.44528
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: PDIA1/P4HB is required for efficient proinsulin maturation and ß cell health in response to diet induced obesity

    Insook Jang / Anita Pottekat / Juthakorn Poothong / Jing Yong / Jacqueline Lagunas-Acosta / Adriana Charbono / Zhouji Chen / Donalyn L Scheuner / Ming Liu / Pamela Itkin-Ansari / Peter Arvan / Randal J Kaufman

    eLife, Vol

    2019  Volume 8

    Abstract: Regulated proinsulin biosynthesis, disulfide bond formation and ER redox homeostasis are essential to prevent Type two diabetes. In ß cells, protein disulfide isomerase A1 (PDIA1/P4HB), the most abundant ER oxidoreductase of over 17 members, can interact ...

    Abstract Regulated proinsulin biosynthesis, disulfide bond formation and ER redox homeostasis are essential to prevent Type two diabetes. In ß cells, protein disulfide isomerase A1 (PDIA1/P4HB), the most abundant ER oxidoreductase of over 17 members, can interact with proinsulin to influence disulfide maturation. Here we find Pdia1 is required for optimal insulin production under metabolic stress in vivo. ß cell-specific Pdia1 deletion in young high-fat diet fed mice or aged mice exacerbated glucose intolerance with inadequate insulinemia and increased the proinsulin/insulin ratio in both serum and islets compared to wildtype mice. Ultrastructural abnormalities in Pdia1-null ß cells include diminished insulin granule content, ER vesiculation and distention, mitochondrial swelling and nuclear condensation. Furthermore, Pdia1 deletion increased accumulation of disulfide-linked high molecular weight proinsulin complexes and islet vulnerability to oxidative stress. These findings demonstrate that PDIA1 contributes to oxidative maturation of proinsulin in the ER to support insulin production and ß cell health.
    Keywords PDIA1 ; proinsulin maturation ; beta cell function ; glucose homeostasis ; disulfide bond formation ; type 2 diabetes ; Medicine ; R ; Science ; Q ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2019-06-01T00:00:00Z
    Publisher eLife Sciences Publications Ltd
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits in hIAPP transgenic mice.

    Templin, Andrew T / Meier, Daniel T / Willard, Joshua R / Wolden-Hanson, Tami / Conway, Kelly / Lin, Yin-Guo / Gillespie, Patrick J / Bokvist, Krister B / Attardo, Giorgio / Kahn, Steven E / Scheuner, Donalyn / Hull, Rebecca L

    Diabetologia

    2018  Volume 61, Issue 10, Page(s) 2215–2224

    Abstract: Aims/hypothesis: Islet amyloid deposits contribute to beta cell dysfunction and death in most individuals with type 2 diabetes but non-invasive methods to determine the presence of these pathological protein aggregates are currently not available. ... ...

    Abstract Aims/hypothesis: Islet amyloid deposits contribute to beta cell dysfunction and death in most individuals with type 2 diabetes but non-invasive methods to determine the presence of these pathological protein aggregates are currently not available. Therefore, we examined whether florbetapir, a radiopharmaceutical agent used for detection of amyloid-β deposits in the brain, also allows identification of islet amyloid in the pancreas.
    Methods: Saturation binding assays were used to determine the affinity of florbetapir for human islet amyloid polypeptide (hIAPP) aggregates in vitro. Islet amyloid-prone transgenic mice that express hIAPP in their beta cells and amyloid-free non-transgenic control mice were used to examine the ability of florbetapir to detect islet amyloid deposits in vitro, in vivo and ex vivo. Mice or mouse pancreases were subjected to autoradiographic, histochemical and/or positron emission tomography (PET) analyses to assess the utility of florbetapir in identifying islet amyloid.
    Results: In vitro, florbetapir bound synthetic hIAPP fibrils with a dissociation constant of 7.9 nmol/l. Additionally, florbetapir bound preferentially to amyloid-containing hIAPP transgenic vs amyloid-free non-transgenic mouse pancreas sections in vitro, as determined by autoradiography (16,475 ± 5581 vs 5762 ± 575 density/unit area, p < 0.05). In hIAPP transgenic and non-transgenic mice fed a high-fat diet for 1 year, intravenous administration of florbetapir followed by PET scanning showed that the florbetapir signal was significantly higher in amyloid-laden hIAPP transgenic vs amyloid-free non-transgenic pancreases in vivo during the first 5 min of the scan (36.83 ± 2.22 vs 29.34 ± 2.03 standardised uptake value × min, p < 0.05). Following PET, pancreases were excised and florbetapir uptake was determined ex vivo by γ counting. Pancreatic uptake of florbetapir was significantly correlated with the degree of islet amyloid deposition, the latter assessed by histochemistry (r = 0.74, p < 0.001).
    Conclusions/interpretation: Florbetapir binds to islet amyloid deposits in a specific and quantitative manner. In the future, florbetapir may be useful as a non-invasive tool to identify islet amyloid deposits in humans.
    MeSH term(s) Amyloid/chemistry ; Aniline Compounds/pharmacology ; Animals ; Body Composition ; Calorimetry, Indirect ; Ethylene Glycols/pharmacology ; Fluorine Radioisotopes/pharmacology ; Gene Expression Regulation ; Glucose Clamp Technique ; Glucose Tolerance Test ; Hypothalamus/metabolism ; Insulin/metabolism ; Insulin Resistance ; Islets of Langerhans/diagnostic imaging ; Ligands ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Polymerase Chain Reaction ; Positron-Emission Tomography ; Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism ; Signal Transduction
    Chemical Substances Amyloid ; Aniline Compounds ; Ethylene Glycols ; Fluorine Radioisotopes ; Insulin ; Ligands ; florbetapir (6867Q6IKOD) ; PTPN1 protein, human (EC 3.1.3.48) ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 (EC 3.1.3.48)
    Language English
    Publishing date 2018-07-25
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1694-9
    ISSN 1432-0428 ; 0012-186X
    ISSN (online) 1432-0428
    ISSN 0012-186X
    DOI 10.1007/s00125-018-4695-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: A selective GPR40 (FFAR1) agonist LY2881835 provides immediate and durable glucose control in rodent models of type 2 diabetes.

    Chen, Yanyun / Song, Min / Riley, Jonathan P / Hu, Charlie C / Peng, Xianbu / Scheuner, Donalyn / Bokvist, Krister / Maiti, Pranab / Kahl, Steven D / Montrose-Rafizadeh, Chahrzad / Hamdouchi, Chafiq / Miller, Anne Reifel

    Pharmacology research & perspectives

    2016  Volume 4, Issue 6, Page(s) e00278

    Abstract: LY2881835 is a selective, potent, and efficacious GPR40 agonist. The objective of the studies described here was to examine the pharmacological properties of LY2881835 in preclinical models of T2D. Significant increases in insulin secretion were detected ...

    Abstract LY2881835 is a selective, potent, and efficacious GPR40 agonist. The objective of the studies described here was to examine the pharmacological properties of LY2881835 in preclinical models of T2D. Significant increases in insulin secretion were detected when LY2881835 was tested in primary islets from WT mice but not in islets from GPR40 KO mice. Furthermore, LY2881835 potentiated glucose stimulated insulin secretion in normal lean mice. Acute administration of LY2881835 lowered glucose during OGTTs in WT mice but not in GPR40 KO mice. These findings demonstrate that LY2881835 induces GPR40-mediated activity ex vivo and in vivo. LY2881835 was administered orally at 10 mg/kg to diet-induced obese (DIO) mice (an early model of T2D due to insulin resistance) for 14 days. Statistically significant reductions in glucose were seen during OGTTs performed on days 1 and 15. When a study was done for 3 weeks in Zucker fa/fa rats, a rat model of insulin resistance, normalization of blood glucose levels equivalent to those seen in lean rats was observed. A similar study was performed in streptozotocin (STZ)-treated DIO mice to explore glucose control in a late model of T2D. In this model, pancreatic insulin content was reduced ~80% due to STZ-treatment plus the mice were insulin resistant due to their high fat diet. Glucose AUCs were significantly reduced during OGTTs done on days 1, 7, and 14 compared to control mice. In conclusion, these results demonstrate that LY2881835 functions as a GPR40-specific insulin secretagogue mediating immediate and durable glucose control in rodent models of early- and late-stage T2D.
    Language English
    Publishing date 2016-11-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2740389-0
    ISSN 2052-1707
    ISSN 2052-1707
    DOI 10.1002/prp2.278
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Ppp1r15 gene knockout reveals an essential role for translation initiation factor 2 alpha (eIF2alpha) dephosphorylation in mammalian development.

    Harding, Heather P / Zhang, Yuhong / Scheuner, Donalyn / Chen, Jane-Jane / Kaufman, Randal J / Ron, David

    Proceedings of the National Academy of Sciences of the United States of America

    2009  Volume 106, Issue 6, Page(s) 1832–1837

    Abstract: Diverse cellular stress responses are linked to phosphorylation of serine 51 on the alpha subunit of translation initiation factor 2. The resultant attenuation of protein synthesis and activation of gene expression figure heavily in the adaptive response ...

    Abstract Diverse cellular stress responses are linked to phosphorylation of serine 51 on the alpha subunit of translation initiation factor 2. The resultant attenuation of protein synthesis and activation of gene expression figure heavily in the adaptive response to stress, but dephosphorylation of eIF2(alphaP), which terminates signaling in this pathway, is less well understood. GADD34 and CReP, the products of the related mammalian genes Ppp1r15a and Ppp1r15b, can recruit phosphatase catalytic subunits of the PPP1 class to eIF2(alphaP), but the significance of their contribution to its dephosphorylation has not been explored systematically. Here we report that unlike Ppp1r15a mutant mice, which are superficially indistinguishable from wild type, Ppp1r15b(-/-) mouse embryos survive gestation but exhibit severe growth retardation and impaired erythropoiesis, and loss of both Ppp1r15 genes leads to early embryonic lethality. These loss-of-function phenotypes are rescued by a mutation, Eif2a(S51A), that prevents regulated phosphorylation of eIF2alpha. These findings reveal that the essential process of eIF2(alphaP) dephosphorylation is the predominant role of PPP1R15 proteins in mammalian development.
    MeSH term(s) Animals ; Antigens, Differentiation/genetics ; Cell Cycle Proteins/genetics ; Embryo, Mammalian ; Erythropoiesis ; Eukaryotic Initiation Factor-2/metabolism ; Eukaryotic Initiation Factor-2/physiology ; Female ; Fetal Death ; Gene Knockout Techniques ; Growth Disorders ; Growth and Development/genetics ; Mice ; Protein Phosphatase 1/genetics
    Chemical Substances Antigens, Differentiation ; Cell Cycle Proteins ; Eukaryotic Initiation Factor-2 ; Ppp1r15a protein, mouse (EC 3.1.3.16) ; Ppp1r15b protein, mouse (EC 3.1.3.16) ; Protein Phosphatase 1 (EC 3.1.3.16)
    Language English
    Publishing date 2009-01-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.0809632106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Phosphorylation of eukaryotic translation initiation factor 2alpha coordinates rRNA transcription and translation inhibition during endoplasmic reticulum stress.

    DuRose, Jenny B / Scheuner, Donalyn / Kaufman, Randal J / Rothblum, Lawrence I / Niwa, Maho

    Molecular and cellular biology

    2009  Volume 29, Issue 15, Page(s) 4295–4307

    Abstract: The endoplasmic reticulum (ER) is the major cellular compartment where folding and maturation of secretory and membrane proteins take place. When protein folding needs exceed the capacity of the ER, the unfolded protein response (UPR) pathway modulates ... ...

    Abstract The endoplasmic reticulum (ER) is the major cellular compartment where folding and maturation of secretory and membrane proteins take place. When protein folding needs exceed the capacity of the ER, the unfolded protein response (UPR) pathway modulates gene expression and downregulates protein translation to restore homeostasis. Here, we report that the UPR downregulates the synthesis of rRNA by inactivation of the RNA polymerase I basal transcription factor RRN3/TIF-IA. Inhibition of rRNA synthesis does not appear to involve the well-characterized mTOR (mammalian target of rapamycin) pathway; instead, PERK-dependent phosphorylation of eIF2alpha plays a critical role in the inactivation of RRN3/TIF-IA. Downregulation of rRNA transcription occurs simultaneously or slightly prior to eIF2alpha phosphorylation-induced translation repression. Since rRNA is the most abundant RNA species, constituting approximately 90% of total cellular RNA, its downregulation exerts a significant impact on cell physiology. Our study demonstrates the first link between regulation of translation and rRNA synthesis with phosphorylation of eIF2alpha, suggesting that this pathway may be broadly utilized by stresses that activate eIF2alpha kinases in order to coordinately regulate translation and ribosome biogenesis during cellular stress.
    MeSH term(s) Animals ; Blotting, Western ; Chromatin Immunoprecipitation ; Electrophoresis, Polyacrylamide Gel ; Endoplasmic Reticulum/metabolism ; Eukaryotic Initiation Factor-2/chemistry ; Eukaryotic Initiation Factor-2/genetics ; Eukaryotic Initiation Factor-2/metabolism ; Gene Expression Regulation ; HeLa Cells ; Humans ; Mice ; NIH 3T3 Cells ; Phosphorylation ; Pol1 Transcription Initiation Complex Proteins ; Protein Biosynthesis ; Protein Folding ; Protein Kinases/genetics ; Protein Kinases/metabolism ; RNA, Ribosomal/genetics ; Signal Transduction ; TOR Serine-Threonine Kinases ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Transcription, Genetic ; eIF-2 Kinase/genetics ; eIF-2 Kinase/metabolism
    Chemical Substances Eukaryotic Initiation Factor-2 ; Pol1 Transcription Initiation Complex Proteins ; RNA, Ribosomal ; RRN3 protein, human ; Transcription Factors ; Protein Kinases (EC 2.7.-) ; MTOR protein, human (EC 2.7.1.1) ; TOR Serine-Threonine Kinases (EC 2.7.1.1) ; mTOR protein, mouse (EC 2.7.1.1) ; PERK kinase (EC 2.7.11.1) ; eIF-2 Kinase (EC 2.7.11.1)
    Language English
    Publishing date 2009-05-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 779397-2
    ISSN 1098-5549 ; 0270-7306
    ISSN (online) 1098-5549
    ISSN 0270-7306
    DOI 10.1128/MCB.00260-09
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top